chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the Moderna COVID-19 first shot  vaccination at 11:00am  on  Thursday, 3/4/21.  The next day,  Friday, 3/5/21,  at about 10:00am, I experienced chills and muscle fatigue that lasted until  bedtime about 11:00pm.  Life returned to normal until yesterday, 3/8/21,  when, beginning around 11:00pm and lasting until 11:00pm bedtime,  I experience body chills similar to 3/5/21.  Today,  Tuesday,  3/9/21, when I awoke at 6:00pm, my heart rate was noticeably elevated but stabilized within 15 minutes.  And about 10:55am, as I was focusing on work (reviewing/editing an electronic document), I  had an unusual blurry vision and mentally spacious experience that lasted for less than 2 minutes but required me to halt work and collect my thoughts. These experiences are completely new to me.
Nausea; chills; fatigue; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP) for a Pfizer sponsored program.    A 73 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "diarrhea" (unspecified if ongoing), notes: she had diarrhea when she first started meds but has not had any in a while. Concomitant medication(s) included: IBRANCE, start date: 30Sep2019. Vaccination history included: Covid-19 vaccine (Dose 1 MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: NAUSEA (non-serious), outcome "unknown", described as "Nausea"; CHILLS (non-serious), outcome "unknown", described as "chills"; FATIGUE (non-serious), outcome "unknown", described as "fatigue". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a health professional concerning three female patients who on approximately 23-JAN-2008 were vaccinated intramuscularly with Gardasil. On 23-JAN-2008 the patient experienced discoloration at the injection site. The discoloration was a lighter skin color where the band aid was in contact with the skin. No further information was provided. The patients sought unspecified medical attention. Additional information has been requested.
states after the 1st two doses, she had little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (states after the 1st two doses, she had little sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A, 006M20A and 0451B21A) for COVID-19 vaccination.     The patient's past medical history included Kidney failure (stage 3 kidney failure). Concurrent medical conditions included Blood pressure high (high blood pressure).   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (states after the 1st two doses, she had little sore arm). At the time of the report, MYALGIA (states after the 1st two doses, she had little sore arm) outcome was unknown.            No concomitant medications were not reported. No treatment medications were not provided.   This case was linked to MOD-2021-308184, MOD-2021-308108 (Patient Link).
Body aches; fever of 100.6F; abdominal pain; headaches; fatigue; anxiety; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PAIN (Body aches), PYREXIA (fever of 100.6F), ABDOMINAL PAIN (abdominal pain), HEADACHE (headaches) and FATIGUE (fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse effect.    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced PAIN (Body aches), PYREXIA (fever of 100.6F), ABDOMINAL PAIN (abdominal pain), HEADACHE (headaches), FATIGUE (fatigue) and ANXIETY (anxiety). At the time of the report, PAIN (Body aches), HEADACHE (headaches), FATIGUE (fatigue) and ANXIETY (anxiety) had not resolved and PYREXIA (fever of 100.6F) and ABDOMINAL PAIN (abdominal pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Jan-2021, Body temperature (100.6-Unknown): Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: No specific follow-up information recorded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient came to clinic to receive MMR and Varicella and the patient qualified for both. However, the nurse gave the combination vaccine instead of the seperate antigens by mistake. Patient was seen in the clinic for other services 3/20/23 and stated that he has had no adverse reactions.
Started feeling discomfort in left shoulder when raises arm up or to lift something or when I move my arm up. Plans to take ibuprofen.
Case PHEH2016US023365 is an initial spontaneous report received from nurse on 13 Sep 2016. This case refers to 53 year old patient of unknown gender. Past medical history and concomitant medications were not reported. The patient was vaccinated with single dose of FLUVIRIN (batch number: 1515701, expiry date: not reported) at a dose of 0.5 ml intramuscular into left arm on 01 Dec 2015. It was reported that, the patient received FLUVIRIN MDV that had been exposed to 8 to 10 temperature excursion and it was administered to unknown number of patients. No adverse event was reported following this medication error.
I was at work ( I am emergency doc) on the day following the vaccine. That day I woke up with some pain only at palpation of the right deltoid muscle at the site of the injection. At about 1p, I began to feel cold and soon after that my teeth began to chatter and I began to have rigors. I continued to work and left at 330p, as usual. I reached home at about 430p and took my temperature: 102.2F. I took 1000mg acetaminophen and 600mg ibuprofen. At that time I had stopped shivering. I had dinner without problems and went to bed at approx. 1000p, repeating the dose of both meds. I woke up at 5 the following morning and reached to work by 0700a. Symptoms did not reoccur. Deltoid pain was gone by morning as well. I rationalized the event as a boost reaction, as I had Covid-19 in July 2020.
2 or 3hr p/vax pt devel fever of 100, tylenol given; fever went to 103 for 3day, neither motrin or tylenol relieved fever past 102, very irritable
DiscomfoRt in chest- tightness/puLLing sensation - palpatations  decrease in sleep swelling/soreness in L ARM x 5 days  -shoulder to elbow
pt recvd vax; 1 day later, pt devel erythema, swelling & tenderness at inject site;
This spontaneous case, initially received on 06-Dec-2016, was reported by a health professional and concerns an adult patient of unknown age and gender. Weight: not provided; Height: not provided. Concomitant medication: not reported. Administration of company suspect drug(s): On an unknown date, the patient received AFLURIA (pre-filled syringe). Dose regimen: Not reported, Route of administration: Not Reported. Batch number: WT52005 or WT56607. No additional suspect drugs. Adverse reactions/events and outcomes: On an unknown date within one week of being dosed, the patient experienced fatigue (outcome: not reported), flu like symptoms (outcome: not reported), nausea (outcome: not reported, vomiting (outcome: not reported).
Pt received vaccine after reporting an allergy to cats.  It was decided to place pt on a 30 minute observation period.  About 20 minutes after receiving the vaccine, pt c/o "tickle in throat" which progressed to "feeling like something is stuck in my throat when I swallow".  EMT on site evaluated pt.  SPO2 was 99% on RA, RR- WNL, lungs clear to auscultation, and pt was able to carry on a normal conversation.  Pt continued to c/o "feeling like something is stuck in my throat" and "restrictions when swallowing".  No s/s of distress noted.  Offered pt 50 mg of Benadryl per protocol, but informed pt that he would need to have someone come to drive him home.  Pt refused Benadryl, stating that he didn't have anyone to drive him home.  PHN called Dr. , pt's PMD to see if Dr. wanted to see the pt in his office. Dr. stated to send pt to Hospital ER for evaluation.  Pt informed of order from Dr. Sent to ER.
Began noticing tinnitus in the right ear within the first 24 hours of receiving the vaccine.  I had no previous signs of tinnitus before.  I am still dealing with the tinnitus 5 months after.
Dry heaves; Kidney pain; Felt like he was burning up; Body shakes throughout the night that were cold and hot; Fatigue; Vomiting; Headache behind the eyes; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of RETCHING (Dry heaves), RENAL PAIN (Kidney pain), FEELING HOT (Felt like he was burning up), FEELING OF BODY TEMPERATURE CHANGE (Body shakes throughout the night that were cold and hot) and MYALGIA (Body aches) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced MYALGIA (Body aches). On 17-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RETCHING (Dry heaves), RENAL PAIN (Kidney pain), FEELING HOT (Felt like he was burning up), FEELING OF BODY TEMPERATURE CHANGE (Body shakes throughout the night that were cold and hot), FATIGUE (Fatigue), VOMITING (Vomiting) and HEADACHE (Headache behind the eyes). On 20-May-2021, MYALGIA (Body aches) had resolved. On 18-Jun-2021, RETCHING (Dry heaves), RENAL PAIN (Kidney pain), FEELING HOT (Felt like he was burning up), VOMITING (Vomiting) and HEADACHE (Headache behind the eyes) had resolved. On 22-Jun-2021, FATIGUE (Fatigue) had resolved. At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (Body shakes throughout the night that were cold and hot) had resolved.            No concomitant medications were reported.  No treatment information was provided.    This case was linked to MOD-2021-232322 (Patient Link).
Child had swelling in the injection area (right arm). Parent was advise to apply warm/cold compresses and move arm as much as possible.
SEVERE MUSCLE ACHES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 11-JUN-2021, the subject experienced severe muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe muscle aches. This report was non-serious.
all the possible side effects being reported; Patient was really bad, she couldn't even move; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (all the possible side effects being reported) and HYPOKINESIA (Patient was really bad, she couldn't even move) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced ADVERSE REACTION (all the possible side effects being reported) and HYPOKINESIA (Patient was really bad, she couldn't even move). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. At the time of the report, ADVERSE REACTION (all the possible side effects being reported) and HYPOKINESIA (Patient was really bad, she couldn't even move) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: No significant information was received.
10x8cm injection site redness on left arm, had some vasovagal syncope while in the office to follow up on reaction.
PATIENT FAINTED APPROXIMATELY 1 MINUTE AFTER BEING ADMINISTERED THE INFLUENZA VACCINATION.  NO S/S WERE PRESENT TO ME (THE VA) PRIOR TO BEING GIVEN THIS SHOT.  PT WAS PLACED ON THE FLOOR, AND AFTER ABOUT 2 MINUTES, SHE AWAKENED.  PATIENT HAD NO RECOLLECTION OF THE EVENT.  HER PULSE WAS TAKEN AT THIS TIME, AND IT WAS 54 BPM.  AMBULANCE WAS CALLED, AND PATIENT WAS CHECKED OUT BY THE PARAMEDICS, BUT SHE REFUSED TO GO TO THE HOSPITAL.  SHE WAS GIVEN A SODA AND ASKED TO SIT IN OUR WAITING ROOM FOR A FEW MINUTES.  HER HUSBAND WAS CALLED TO COME AND PICK HER UP.  I BELIEVE SHE WENT TO THE DOCTOR 2 DAYS LATER AND WAS TOLD THAT SHE WAS VERY FATIGUED AT THE TIME THE VACCINE WAS ADMINISTERED.  PT HAS RECEIVED FLU SHOTS IN THE PAST WITH NO PROBLEMS.
The mother put the child's date of birth on the administration form and the scheduling tool (upon making the appointment). Upon billing the insurance, the date of birth as given was rejected. The insurance was called and the representative stated the date of birth for the child is incorrect. The mother was called to verify which date of birth was correct. She later admitted that the date of birth of the child was indeed incorrect and the child was 11.
I exp 3 1/2 x 5 inch red rash around the injection site,muscle cramps and  few joint pains. It was still present when I received my 2nd dose.The size of the rash around injection site is significant.
13:25 Patient received vaccination. 13:38 Observation staff noted patient looked fatigue and requested clinician to examine patient.  13:40 Clinician inquires about s/sx. Patient appeared not in distress. Speech cohesive and comprehensive. Patient noted body weakness 5 minutes post-vaccination. 13:42 Clinician asked scriber to obtain water for patient and RN to continue observing while clinician obtains sphygmomanometer and stethoscope.  13:43 Clinician obtained vital signs manually. BP: 132/84 P: 74 RRR. No adventitious sounds. Clinician continued to monitor for additional 15 minutes. 13:58 Patient informed clinician he feels better. Clinician observed patient completed one 8 fl oz water bottle. Clinician informed patient to rest and push fluids for rest of day however patient needs to return to work. So informed him to perform light duties if he needs to return to work. Clinician provided precaution to seek medical attention if patient develops difficulty breathing or chest pain/discomfort. Patient verbalizes understanding.
1:30pm Post vaccination reports feeling dizzy w/headache; medical monitoring x30 min w/ vitals assessment: BP 129/91 O 83 RR 19 O2sat 99%, rest, juice and snack consumed. 2:04pm NAD, reports "feeling better", no additional complaints / symptoms noted. Released from facility w/ self
Welts, rash, shedding of skin Treating with po benadryl 25 mg and gel
His arm felt a little hot and stiffer than the left arm; Right arm felt stiffer than left arm; Swollen right arm; Red right arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (His arm felt a little hot and stiffer than the left arm), VACCINATION SITE INDURATION (Right arm felt stiffer than left arm), VACCINATION SITE SWELLING (Swollen right arm) and VACCINATION SITE ERYTHEMA (Red right arm) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included VITAMINS NOS, ATORVASTATIN CALCIUM (LIPITOR), VALSARTAN and OMEPRAZOLE for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (His arm felt a little hot and stiffer than the left arm), VACCINATION SITE INDURATION (Right arm felt stiffer than left arm), VACCINATION SITE SWELLING (Swollen right arm) and VACCINATION SITE ERYTHEMA (Red right arm). At the time of the report, VACCINATION SITE WARMTH (His arm felt a little hot and stiffer than the left arm), VACCINATION SITE INDURATION (Right arm felt stiffer than left arm), VACCINATION SITE SWELLING (Swollen right arm) and VACCINATION SITE ERYTHEMA (Red right arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
achy in my legs and my back; achy in my legs and my back; felt like I was going to throw up; This is a spontaneous report received from a contactable reporter (other healthcare professional) from medical information team. The reporter is the patient.  A 56-year-old female patient received bnt162b2 (PFIZER-BIOTECH COVID-19 mRNA VACCINE, solution for injection) (Lot number: EN6200) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), BACK PAIN (non-serious), outcome "unknown" and all described as "achy in my legs and my back"; NAUSEA (non-serious), outcome "unknown", described as "felt like I was going to throw up".  No follow-up attempts are possible. No further information is expected.
Erythema & itching at injection site. No fever, facial swelling or resp difficulty noted.
Heart palpitation, shortness of breath, weakness in limb, strange sensation in back of head
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Additional Details: family told me something wrong. I checked up the patient was flustered with emotion. I just advise to give benadryl to calm the patient and rule off in case she wasn't able to breathe. Patient did what was described as a vasor motor response in which the patient was anxious of the shot. she did have a slight tear to which I did mention if it was painful  at all and was told no.  I also gave her water and monitored for another 5 minutes.  patient had no issue with 1st shot
Fifteen hours after the vaccine my son woke up and his respiratory rate was high. It was over 140. I woke him up and he had chills and diarrhea. Because of his Cortisol Deficiency I called his doctor. I was advised to give him 30mg Hydrocortisone and lots of water.  His Respiratory and heart rate were high. He was feeling a little short of breath and he had heart palpitations. We went to the ER and they did lots of testing. He had a fever and Sepsis testing. All results were normal and they gave him a Liter of fluids. He was discharged after two hours and his pulse was still high at 105-110. We monitored him and his heart rate was slowing and he started to feel better. His Endocrinologist had him take a double dose of Hydrocortisone the next day. His improvement progressed and by the fourth day the symptoms were gone.  He was able to do his normal activities but tired and worn out from the ordeal. One week later he had a slightly elevated heart rate but it resolved quickly.  He had had a local reaction in his arm with swelling and a rash after the first vaccine.
LOCAL DTAP REACTION.  14X12CM AREA OF PINK WARM INDURATION UPPER ARM/LOWER SHOULDER
testing positive for COVID after receiving vaccine; testing positive for COVID after receiving vaccine; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar event for 14 patients. This is 11th of 14 report. An elderly patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number and expiration date unknown a not available/provided to reporter at the time of report completion), via an unspecified route of administration on 13Jan2021 at single dose for COVID-19 immunisation. The patient's medical history was not reported. For concomitant medications, it was unknown if other vaccine in four weeks or other medications in two weeks. The patient was testing positive for COVID after receiving vaccine. A total of 8 patients and 6 workers at a long term care facility were vaccinated on 13Jan2021 and reported testing positive for COVID on 21Jan2021. Since they were testing positive, physician wanted to administer bamlanirimab (drug being administered under FDA EUA). The events start date was 21Jan2021, and resulting in doctor or other healthcare professional office/clinic visit. It was reported as unknown if treatment was taken for the events. The outcome of the events was unknown. It was unknown if patient had COVID prior to this vaccination. The patient had been tested post vaccination.  Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be excluded for reported "testing positive for COVID after receiving vaccine".,Linked Report(s) : US-PFIZER INC-2021063794 same reporter/drug/event, different patient.
Patient stated about 4 to 5 days after getting flu shot- she woke up to shoulder pain. Up until that point, she stated she experienced the usual muscle soreness associated with a shot.  Over the last couple of days, the pain has worsened. She also states it's hard to move her arm from the elbow up to the shoulder, with limited range of motion
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 72-year-old female patient who received Influenza vaccine Quadrivalent. Concomitant products included Aspirin, Vitamin C, vitamin D and NOS Multivitamin. In August 2017, the patient received Influenza vaccine Quadrivalent (intramuscular). In August 2017, less than a day after receiving Influenza vaccine Quadrivalent, the patient experienced injection site erythema and pain in arm. On an unknown date, the outcome of the injection site erythema and pain in arm were recovered/resolved. The reporter considered the injection site erythema and pain in arm to be related to Influenza vaccine Quadrivalent. Additional information was reported as follows: The patient stated that, she received the flu vaccine; she was not sure which flu vaccine she received. The manufacturer of the vaccine was unknown. The patient reported that, after vaccination, later on the same day, she experienced redness to the size of a dime at the injections site and soreness in her right arm as well. She also reported that the redness and soreness only lasted 2 or 3 days then went away.